OTC bulletin-i provides intelligence on the move for the consumer healthcare industry. Its subscribers benefit from the latest commercial intelligence about business opportunities in the worldwide self-medication market.
They also get access to more than five years of back issues in a fully-searchable archive. This offers an invaluable resource for researching market opportunities, benchmarking competitive strengths, evaluating regulatory changes and assessing product developments.
Senior executives in the world's leading global, regional and national consumer healthcare companies – as well as a broad spectrum of industry watchers and suppliers – make sure they regularly read OTC bulletin.
Published 20-times a year – twice-monthly in most months – its accurate and reliable reports provide insights into the strategies of significant non-prescription medicine and dietary supplement firms and analyse their business performance, plans and product portfolios.
An annual subscription for 20 issues and complete access to the fully-searchable OTC bulletin archive, dating back to the beginning of 2008, costs £975. Any queries you may have about subscriptions should be addressed to [email protected]
Prescription-to-OTC switches, umbrella branding, innovative line extensions, consumer communications, borderline disputes, and developments in herbal medicines and OTC medical devices are some of the issues and topics that provide the wider context for OTC bulletin's comprehensive global coverage.
With subscribers in over 45 countries, OTC bulletin is read by senior executives engaged in developing, licensing, manufacturing, distributing or marketing non-prescription medicines and dietary supplements, as well as those supplying goods and services to the consumer healthcare industry.
Bug fixes and enhancements